ALK and lung cancer: increased signalling via signal transducer and activator of transcription 3 (STAT3), extracellular regulated kinases (ERK) and epidermal growth factor receptor (EGFR) [37–40], inactivation of phosphatase and tensin homolog (PTEN) [41] and the ALK mutation in lung cancer [42].